Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells

Detalles Bibliográficos
Autores principales: Yang, Qu, Zhang, Shanyong, Kang, Mingyang, Dong, Rongpeng, Zhao, Jianwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317159/
https://www.ncbi.nlm.nih.gov/pubmed/34278510
http://dx.doi.org/10.3892/or.2021.8144
_version_ 1783730016934166528
author Yang, Qu
Zhang, Shanyong
Kang, Mingyang
Dong, Rongpeng
Zhao, Jianwu
author_facet Yang, Qu
Zhang, Shanyong
Kang, Mingyang
Dong, Rongpeng
Zhao, Jianwu
author_sort Yang, Qu
collection PubMed
description
format Online
Article
Text
id pubmed-8317159
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-83171592021-07-31 Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells Yang, Qu Zhang, Shanyong Kang, Mingyang Dong, Rongpeng Zhao, Jianwu Oncol Rep Retraction D.A. Spandidos 2021-09 2021-07-16 /pmc/articles/PMC8317159/ /pubmed/34278510 http://dx.doi.org/10.3892/or.2021.8144 Text en Copyright: © Yang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Retraction
Yang, Qu
Zhang, Shanyong
Kang, Mingyang
Dong, Rongpeng
Zhao, Jianwu
Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
title Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
title_full Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
title_fullStr Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
title_full_unstemmed Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
title_short Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
title_sort synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317159/
https://www.ncbi.nlm.nih.gov/pubmed/34278510
http://dx.doi.org/10.3892/or.2021.8144
work_keys_str_mv AT yangqu synergisticgrowthinhibitionbysorafenibandcisplatininhumanosteosarcomacells
AT zhangshanyong synergisticgrowthinhibitionbysorafenibandcisplatininhumanosteosarcomacells
AT kangmingyang synergisticgrowthinhibitionbysorafenibandcisplatininhumanosteosarcomacells
AT dongrongpeng synergisticgrowthinhibitionbysorafenibandcisplatininhumanosteosarcomacells
AT zhaojianwu synergisticgrowthinhibitionbysorafenibandcisplatininhumanosteosarcomacells

Ejemplares similares